Immediate Impact
20 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer
2024 Standout
Works of Jiali Lin being referenced
Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jiali Lin | 94 | 103 | 119 | 34 | 308 | |
| Shigeki Namimatsu | 54 | 142 | 52 | 17 | 311 | |
| Annette Raabe | 73 | 90 | 42 | 27 | 273 | |
| Shuhei Noda | 62 | 88 | 68 | 24 | 262 | |
| Ru Yao | 149 | 100 | 132 | 39 | 362 | |
| Krzysztof Glomski | 49 | 131 | 49 | 21 | 334 | |
| Shi Wang | 104 | 189 | 39 | 21 | 297 | |
| Jinhua Zhang | 87 | 196 | 70 | 22 | 368 | |
| Zhu Xin | 117 | 149 | 45 | 22 | 287 | |
| R. De Vita | 124 | 92 | 59 | 26 | 364 | |
| Qiuxia Yan | 58 | 169 | 34 | 23 | 288 |
All Works
Loading papers...